Asia Pacific Cranial Implants Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

Description

List of Tables

The Asia Pacific cranial implants market is projected to grow significantly, reaching approximately US$ 436.54 million by 2031, up from US$ 248.40 million in 2023, with a compound annual growth rate (CAGR) of 7.3% during the forecast period.

Executive Summary and Market Analysis

The Asia Pacific region is recognized as the fastest-growing market for cranial implants globally. This market encompasses several countries, including China, Japan, India, South Korea, Australia, and other regions within Asia Pacific. Key contributors to the market's expansion include China, India, and Japan, driven by an increasing elderly population and a rise in neurological disorders. These factors are expected to propel market growth in the coming years. Additionally, government initiatives and awareness campaigns by non-governmental organizations are further enhancing market dynamics. The presence of numerous industry players in countries like Japan, China, and India also plays a crucial role in the market's development.

Market Segmentation Analysis

The Asia Pacific cranial implants market can be segmented based on type, material, and application:

By Type: The market is divided into parietal, frontal, occipital, temporal, and sphenoid implants. In 2023, parietal implants held the largest market share.
By Material: The segmentation includes polymethyl methacrylate, polyether ether ketone, titanium, and others, with polyether ether ketone leading the market in 2023.
By End User: The market is categorized into hospitals, trauma centers, and others, where hospitals accounted for the largest share in 2023.

Market Outlook

The advent of 3D printing technology, also known as additive manufacturing, is revolutionizing the production of cranial implants. This technology allows for the creation of highly customized, patient-specific implants that offer better fit and functionality compared to traditional options. The ability to replicate an individual's skull geometry precisely reduces surgical complications and enhances recovery outcomes. Furthermore, the integration of multilayer technology in 3D printing enables the production of implants with varying properties tailored for specific functions, such as structural strength and biocompatibility. This innovation improves osseointegration, minimizes the risk of implant rejection, and provides enhanced protection for the brain.

3D printing also facilitates faster production times, lowers manufacturing costs, and offers greater adaptability to complex cranial deformities. These advancements not only enhance patient outcomes but also make cranial implants more accessible to a wider patient demographic. Consequently, the integration of multilayer technology in 3D printing presents significant opportunities for growth in the cranial implant market.

Country Insights

The Asia Pacific cranial implants market includes key countries such as China, Japan, India, South Korea, Australia, and others, with China holding the largest market share in 2023. According to a study published in 2023, China reported a stroke incidence of 3.4 million and a prevalence of 17.8 million among individuals aged 40 and above in 2020. Each year, around 2 million people experience their first stroke, with a significant percentage unable to live independently. Cranial implants are increasingly utilized in stroke treatment and rehabilitation, serving to protect and reconstruct the skull post-surgery while potentially aiding in motor function recovery.

Moreover, the rising incidence of traumatic brain injuries (TBIs) in China, estimated at approximately 772,800 to 892,800 new cases annually, is driving demand for cranial implants. The rapid socioeconomic development, environmental challenges, lifestyle changes, and urbanization in China pose health maintenance obstacles. The government's Healthy China 2030 Plan highlights the importance of health for economic growth, with substantial investments in healthcare infrastructure and technology aimed at improving access and quality. These initiatives create a favorable environment for the cranial implants market.

Company Profiles

Key players in the Asia Pacific cranial implants market include Stryker Corp, Zimmer Biomet Holdings Inc, Integra LifeSciences Holdings Corp, OsteoMed SA, Anatomics Pty Ltd, Matrix Surgical Holdings LLC, and others. These companies are pursuing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to consumers.

Product Code: BMIRE00031982

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Asia Pacific Cranial Implants Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Asia Pacific Cranial Implants Market - Key Market Dynamics

5.1 Asia Pacific Cranial Implants Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increase in Prevalence of Traumatic Brain Injuries
- 5.2.2 Surge in Elderly Populations
5.3 Market Restraints
- 5.3.1 Risk of Implant Failure
5.4 Market Opportunities
- 5.4.1 Advancements in 3D Printing with Incorporation of Original Multilayer Technology
5.5 Future Trends
- 5.5.1 Customized Implants
5.6 Impact of Drivers and Restraints:

6. Asia Pacific Cranial Implants Market - Analysis

6.1 Asia Pacific Cranial Implants Market Revenue (US$ Million), 2021-2031
6.2 Asia Pacific Cranial Implants Market Forecast Analysis

7. Asia Pacific Cranial Implants Market Analysis - by Type

7.1 Parietal
- 7.1.1 Overview
- 7.1.2 Parietal: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Frontal
- 7.2.1 Overview
- 7.2.2 Frontal: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Occipital
- 7.3.1 Overview
- 7.3.2 Occipital: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Temporal
- 7.4.1 Overview
- 7.4.2 Temporal: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Sphenoid
- 7.5.1 Overview
- 7.5.2 Sphenoid: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Asia Pacific Cranial Implants Market Analysis - by Material

8.1 Polymethyl Methacrylate
- 8.1.1 Overview
- 8.1.2 Polymethyl Methacrylate: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Polyether Ether Ketone
- 8.2.1 Overview
- 8.2.2 Polyether Ether Ketone: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Titanium
- 8.3.1 Overview
- 8.3.2 Titanium: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Others
- 8.4.1 Overview
- 8.4.2 Others: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Asia Pacific Cranial Implants Market Analysis - by End User

9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Trauma Centers
- 9.2.1 Overview
- 9.2.2 Trauma Centers: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Others
- 9.3.1 Overview
- 9.3.2 Others: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Asia Pacific Cranial Implants Market - Country Analysis

10.1 Asia Pacific
- 10.1.1 Asia Pacific Cranial Implants Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 Asia Pacific Cranial Implants Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.2 China: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.2.1 China: Asia Pacific Cranial Implants Market Share - by Type
    - 10.1.1.2.2 China: Asia Pacific Cranial Implants Market Share - by Material
    - 10.1.1.2.3 China: Asia Pacific Cranial Implants Market Share - by End User
  - 10.1.1.3 Japan: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.3.1 Japan: Asia Pacific Cranial Implants Market Share - by Type
    - 10.1.1.3.2 Japan: Asia Pacific Cranial Implants Market Share - by Material
    - 10.1.1.3.3 Japan: Asia Pacific Cranial Implants Market Share - by End User
  - 10.1.1.4 India: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.4.1 India: Asia Pacific Cranial Implants Market Share - by Type
    - 10.1.1.4.2 India: Asia Pacific Cranial Implants Market Share - by Material
    - 10.1.1.4.3 India: Asia Pacific Cranial Implants Market Share - by End User
  - 10.1.1.5 Australia: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.5.1 Australia: Asia Pacific Cranial Implants Market Share - by Type
    - 10.1.1.5.2 Australia: Asia Pacific Cranial Implants Market Share - by Material
    - 10.1.1.5.3 Australia: Asia Pacific Cranial Implants Market Share - by End User
  - 10.1.1.6 South Korea: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.6.1 South Korea: Asia Pacific Cranial Implants Market Share - by Type
    - 10.1.1.6.2 South Korea: Asia Pacific Cranial Implants Market Share - by Material
    - 10.1.1.6.3 South Korea: Asia Pacific Cranial Implants Market Share - by End User
  - 10.1.1.7 Rest of APAC: Asia Pacific Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.7.1 Rest of APAC: Asia Pacific Cranial Implants Market Share - by Type
    - 10.1.1.7.2 Rest of APAC: Asia Pacific Cranial Implants Market Share - by Material
    - 10.1.1.7.3 Rest of APAC: Asia Pacific Cranial Implants Market Share - by End User

11. Industry Landscape

11.1 Overview
11.2 Mergers and Acquisitions
11.3 Product Launch
11.4 Expansions and Other Strategic Developments

12. Company Profiles

12.1 Stryker Corp
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Zimmer Biomet Holdings Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Integra LifeSciences Holdings Corp
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 OsteoMed SA
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Anatomics Pty Ltd
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Matrix Surgical Holdings LLC
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Calavera Surgical
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Medtronic Plc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Xilloc Medical BV
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Johnson & Johnson
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
12.11 evonos GmbH & Co. KG
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
12.12 B Braun SE
- 12.12.1 Key Facts
- 12.12.2 Business Description
- 12.12.3 Products and Services
- 12.12.4 Financial Overview
- 12.12.5 SWOT Analysis
- 12.12.6 Key Developments
12.13 UAB Ortho Baltic
- 12.13.1 Key Facts
- 12.13.2 Business Description
- 12.13.3 Products and Services
- 12.13.4 Financial Overview
- 12.13.5 SWOT Analysis
- 12.13.6 Key Developments
12.14 3D Systems Corp
- 12.14.1 Key Facts
- 12.14.2 Business Description
- 12.14.3 Products and Services
- 12.14.4 Financial Overview
- 12.14.5 SWOT Analysis
- 12.14.6 Key Developments
12.15 GPC Medical Ltd
- 12.15.1 Key Facts
- 12.15.2 Business Description
- 12.15.3 Products and Services
- 12.15.4 Financial Overview
- 12.15.5 SWOT Analysis
- 12.15.6 Key Developments
12.16 Bioplate Inc
- 12.16.1 Key Facts
- 12.16.2 Business Description
- 12.16.3 Products and Services
- 12.16.4 Financial Overview
- 12.16.5 SWOT Analysis
- 12.16.6 Key Developments
12.17 EUROS SAS
- 12.17.1 Key Facts
- 12.17.2 Business Description
- 12.17.3 Products and Services
- 12.17.4 Financial Overview
- 12.17.5 SWOT Analysis
- 12.17.6 Key Developments
12.18 Biocomposites Ltd
- 12.18.1 Key Facts
- 12.18.2 Business Description
- 12.18.3 Products and Services
- 12.18.4 Financial Overview
- 12.18.5 SWOT Analysis
- 12.18.6 Key Developments
12.19 Medprin Biotech GmbH
- 12.19.1 Key Facts
- 12.19.2 Business Description
- 12.19.3 Products and Services
- 12.19.4 Financial Overview
- 12.19.5 SWOT Analysis
- 12.19.6 Key Developments
12.20 Kelyniam Global Inc
- 12.20.1 Key Facts
- 12.20.2 Business Description
- 12.20.3 Products and Services
- 12.20.4 Financial Overview
- 12.20.5 SWOT Analysis
- 12.20.6 Key Developments
12.21 MedCAD
- 12.21.1 Key Facts
- 12.21.2 Business Description
- 12.21.3 Products and Services
- 12.21.4 Financial Overview
- 12.21.5 SWOT Analysis
- 12.21.6 Key Developments
12.22 KLS Martin Group
- 12.22.1 Key Facts
- 12.22.2 Business Description
- 12.22.3 Products and Services
- 12.22.4 Financial Overview
- 12.22.5 SWOT Analysis
- 12.22.6 Key Developments
12.23 Longeviti Neuro Solutions LLC
- 12.23.1 Key Facts
- 12.23.2 Business Description
- 12.23.3 Products and Services
- 12.23.4 Financial Overview
- 12.23.5 SWOT Analysis
- 12.23.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 List of Abbreviations